Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma

Overview of attention for article published in Frontiers in immunology, March 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 11 X posts from 9 X users, with an upper bound of 5,642 followers.

Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma https://t.co/3eVnNsUe3a

Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma https://t.co/xj5F1Pn6nL

New article: Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma https://t.co/hqEU0PpWGF #lungcancer #oncology https://t.co/u1jBhLDggn

New article: Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma https://t.co/yyp1lqFNiF #melanoma #oncology https://t.co/G2tLYnshyU

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.